Announcements Trials
Browse Landscape

Status

Active not recruiting 1

Sponsor Class

OTHER 6OTHER_GOV 1NIH 1NETWORK 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Neoplasms 172Breast Neoplasms 102Prostatic Neoplasms 45Lung Neoplasms 42Lymphoma 37Leukemia 35Brain Neoplasms 35Melanoma 29Ovarian Neoplasms 24Lymphoma, Non-Hodgkin 20Stomach Neoplasms 18HIV Infections 17Colonic Neoplasms 17Esophageal Neoplasms 16Carcinoma, Non-Small-Cell Lung 16Urinary Bladder Neoplasms 15Glioma 15Acquired Immunodeficiency Syndrome 15Sarcoma, Kaposi 14Neoplasm Metastasis 14Leukemia, Myeloid, Acute 14Thyroid Neoplasms 13Precursor Cell Lymphoblastic Leukemia-Lymphoma 13Kidney Neoplasms 13Hematologic Neoplasms 13Endometrial Neoplasms 13Colorectal Neoplasms 13Uterine Cervical Neoplasms 12Sarcoma 12Neurofibromatosis 1 12

Interventions

Vincristine 1Methotrexate 1Mental Status and Dementia Tests 1Magnetic Resonance Spectroscopy 1Cyclophosphamide 1Cisplatin 1Chemotherapy, Adjuvant 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Observational × Ototoxicity × Clear all
NCT00683319 2013-09-20

Observing Young Patients With Ependymoma Undergoing Standard Combination Chemotherapy

National Cancer Institute (NCI)

Active not recruiting
50 enrolled
CNS

Ototoxicity, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡